APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Analysis and Forecast 2026-2032

30 December 2025199 pages

Choose your research edition.

Industry ResearchCytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) include CSL, Biotest, Beijing Tiantan Biological Products, Shanxi Kangbao Biological Product and Taibang Biologic Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV), also provides the sales of main regions and countries. Of the upcoming market potential for Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) sales, projected growth trends, production technology, application and end-user industry.

Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Segment by Company

CSL

Biotest

Beijing Tiantan Biological Products

Shanxi Kangbao Biological Product

Taibang Biologic Group

Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Segment by Type

25ml

50ml

100ml

Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Segment by Application

Hopistial

Clinic

Others

Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 25ml Major Manufacturers Table 3. 50ml Major Manufacturers Table 4. 100ml Major Manufacturers Table 5. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hopistial Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Others Major Manufacturers Table 9. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Industry Trends Table 10. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Industry Drivers Table 11. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Industry Opportunities and Challenges Table 12. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Industry Restraints Table 13. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Region (2021-2026) Table 17. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Region (2027-2032) Table 18. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 19. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Region (2021-2026) & (Units) Table 20. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Region (2027-2032) & (Units) Table 21. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Region (2021-2026) Table 22. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Region (2027-2032) Table 23. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Manufacturers (2021-2026) Table 27. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Manufacturers, Product Type & Application Table 31. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Type (2021-2026) Table 38. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Type (2027-2032) Table 39. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type 2021 VS 2025 VS 2032 (Units) Table 40. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2021-2026) & (Units) Table 41. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2027-2032) & (Units) Table 42. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Type (2021-2026) Table 43. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Type (2027-2032) Table 44. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Type (2021-2026) & (US$/Unit) Table 45. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Type (2027-2032) & (US$/Unit) Table 46. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Application (2021-2026) Table 50. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Application (2027-2032) Table 51. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application 2021 VS 2025 VS 2032 (Units) Table 52. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2021-2026) & (Units) Table 53. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2027-2032) & (Units) Table 54. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Application (2021-2026) Table 55. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Application (2027-2032) Table 56. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Application (2021-2026) & (US$/Unit) Table 57. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Application (2027-2032) & (US$/Unit) Table 58. CSL Company Information Table 59. CSL Business Overview Table 60. CSL Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. CSL Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product Portfolio Table 62. CSL Recent Development Table 63. Biotest Company Information Table 64. Biotest Business Overview Table 65. Biotest Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Biotest Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product Portfolio Table 67. Biotest Recent Development Table 68. Beijing Tiantan Biological Products Company Information Table 69. Beijing Tiantan Biological Products Business Overview Table 70. Beijing Tiantan Biological Products Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Beijing Tiantan Biological Products Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product Portfolio Table 72. Beijing Tiantan Biological Products Recent Development Table 73. Shanxi Kangbao Biological Product Company Information Table 74. Shanxi Kangbao Biological Product Business Overview Table 75. Shanxi Kangbao Biological Product Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Shanxi Kangbao Biological Product Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product Portfolio Table 77. Shanxi Kangbao Biological Product Recent Development Table 78. Taibang Biologic Group Company Information Table 79. Taibang Biologic Group Business Overview Table 80. Taibang Biologic Group Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Taibang Biologic Group Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product Portfolio Table 82. Taibang Biologic Group Recent Development Table 83. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2021-2026) & (US$ Million) Table 84. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2027-2032) & (US$ Million) Table 85. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2021-2026) & (Units) Table 86. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2027-2032) & (Units) Table 87. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Type (2021-2026) & (US$/Unit) Table 88. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Type (2027-2032) & (US$/Unit) Table 89. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2021-2026) & (US$ Million) Table 90. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2027-2032) & (US$ Million) Table 91. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2021-2026) & (Units) Table 92. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2027-2032) & (Units) Table 93. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Application (2021-2026) & (US$/Unit) Table 94. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Application (2027-2032) & (US$/Unit) Table 95. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 97. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 98. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 99. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2021-2026) & (Units) Table 100. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2027-2032) & (Units) Table 101. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Country (2021-2026) & (US$/Unit) Table 102. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Country (2027-2032) & (US$/Unit) Table 103. United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 104. Canada Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 105. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2021-2026) & (Units) Table 108. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2027-2032) & (Units) Table 109. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Type (2021-2026) & (US$/Unit) Table 110. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Type (2027-2032) & (US$/Unit) Table 111. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2021-2026) & (Units) Table 114. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2027-2032) & (Units) Table 115. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Application (2021-2026) & (US$/Unit) Table 116. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Application (2027-2032) & (US$/Unit) Table 117. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 121. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2021-2026) & (Units) Table 122. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2027-2032) & (Units) Table 123. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Country (2021-2026) & (US$/Unit) Table 124. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Country (2027-2032) & (US$/Unit) Table 125. Germany Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 126. France Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 127. U.K. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 128. Italy Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 129. Netherlands Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 130. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2021-2026) & (US$ Million) Table 131. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2027-2032) & (US$ Million) Table 132. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2021-2026) & (Units) Table 133. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2027-2032) & (Units) Table 134. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Type (2021-2026) & (US$/Unit) Table 135. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Type (2027-2032) & (US$/Unit) Table 136. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2021-2026) & (US$ Million) Table 137. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2027-2032) & (US$ Million) Table 138. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2021-2026) & (Units) Table 139. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2027-2032) & (Units) Table 140. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Application (2021-2026) & (US$/Unit) Table 141. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Application (2027-2032) & (US$/Unit) Table 142. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2021-2026) & (Units) Table 145. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2027-2032) & (Units) Table 146. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Type (2021-2026) & (US$/Unit) Table 147. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Type (2027-2032) & (US$/Unit) Table 148. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2021-2026) & (US$ Million) Table 149. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2021-2026) & (Units) Table 151. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2027-2032) & (Units) Table 152. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Application (2021-2026) & (US$/Unit) Table 153. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Application (2027-2032) & (US$/Unit) Table 154. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 158. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2021-2026) & (Units) Table 159. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2027-2032) & (Units) Table 160. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Country (2021-2026) & (US$/Unit) Table 161. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Country (2027-2032) & (US$/Unit) Table 162. Japan Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 163. South Korea Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 164. India Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 165. Australia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 166. China Taiwan Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 167. Southeast Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 168. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2021-2026) & (US$ Million) Table 169. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2027-2032) & (US$ Million) Table 170. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2021-2026) & (Units) Table 171. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2027-2032) & (Units) Table 172. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Type (2021-2026) & (US$/Unit) Table 173. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Type (2027-2032) & (US$/Unit) Table 174. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2021-2026) & (US$ Million) Table 175. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2027-2032) & (US$ Million) Table 176. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2021-2026) & (Units) Table 177. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2027-2032) & (Units) Table 178. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Application (2021-2026) & (US$/Unit) Table 179. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Application (2027-2032) & (US$/Unit) Table 180. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 184. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2021-2026) & (Units) Table 185. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2027-2032) & (Units) Table 186. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Country (2021-2026) & (US$/Unit) Table 187. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Country (2027-2032) & (US$/Unit) Table 188. Brazil Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 189. Argentina Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 190. Chile Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 191. Colombia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 192. Peru Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 193. Saudi Arabia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 194. Israel Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 195. UAE Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 196. Turkey Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 197. Iran Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 198. Egypt Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Table 199. Key Raw Materials Table 200. Raw Materials Key Suppliers Table 201. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Distributors List Table 202. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Customers List Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources Table 206. Primary Sources List of Figures Figure 1. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Image Figure 2. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size Share 2021 VS 2025 VS 2032 Figure 4. 25ml Image Figure 5. 50ml Image Figure 6. 100ml Image Figure 7. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hopistial Image Figure 10. Clinic Image Figure 11. Others Image Figure 12. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (2021-2032) & (US$ Million) Figure 14. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Region (2021-2032) Figure 17. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales (2021-2032) & (Units) Figure 18. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 19. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales YoY (2021-2032) & (Units) Figure 21. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales YoY (2021-2032) & (Units) Figure 22. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales YoY (2021-2032) & (Units) Figure 23. Asia (Excluding China) Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales YoY (2021-2032) & (Units) Figure 24. South America, Middle East and Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales YoY (2021-2032) & (Units) Figure 25. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Type (2021-2032) Figure 31. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 32. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Type (2021-2032) Figure 34. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Application (2021-2032) Figure 37. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 38. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Application (2021-2032) Figure 40. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Share by Type (2021-2032) Figure 41. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Share by Type (2021-2032) Figure 42. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Share by Application (2021-2032) Figure 43. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Share by Application (2021-2032) Figure 44. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Share by Country (2021-2032) Figure 45. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Share by Country (2021-2032) Figure 46. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Share by Type (2021-2032) Figure 47. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Share by Type (2021-2032) Figure 48. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Share by Application (2021-2032) Figure 49. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Share by Application (2021-2032) Figure 50. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Share by Country (2021-2032) Figure 51. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Share by Country (2021-2032) Figure 52. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Share by Type (2021-2032) Figure 53. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Share by Type (2021-2032) Figure 54. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Share by Application (2021-2032) Figure 55. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Share by Application (2021-2032) Figure 56. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Share by Type (2021-2032) Figure 57. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Share by Type (2021-2032) Figure 58. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Share by Application (2021-2032) Figure 59. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Share by Application (2021-2032) Figure 60. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Share by Country (2021-2032) Figure 61. Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Share by Country (2021-2032) Figure 62. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Share by Type (2021-2032) Figure 63. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Share by Type (2021-2032) Figure 64. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Share by Application (2021-2032) Figure 65. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Share by Application (2021-2032) Figure 66. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Share by Country (2021-2032) Figure 67. SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Share by Country (2021-2032) Figure 68. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executiv

Scope & coverage.

Types
  • 25ml
  • 50ml
  • 100ml
Applications
  • Hopistial
  • Clinic
  • Others
Companies covered
  • CSL
  • Biotest
  • Beijing Tiantan Biological Products
  • Shanxi Kangbao Biological Product
  • Taibang Biologic Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market by Type
  3. 1.2.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 25ml
  5. 1.2.3 50ml
  6. 1.2.4 100ml
  7. 1.3 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market by Application
  8. 1.3.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hopistial
  10. 1.3.3 Clinic
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Dynamics
  1. 2.1 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Industry Trends
  2. 2.2 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Industry Drivers
  3. 2.3 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Industry Opportunities and Challenges
  4. 2.4 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Region
  3. 3.2.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Region (2021-2026)
  5. 3.2.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Region (2027-2032)
  6. 3.2.4 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Region
  9. 3.4.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Region (2021-2026)
  11. 3.4.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Region (2027-2032)
  12. 3.4.4 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Manufacturers
  2. 4.1.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Manufacturers
  6. 4.2.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Manufacturers, Product Type & Application
  13. 4.7 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market CR5 and HHI
  16. 4.8.2 2025 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Tier 1, Tier 2, and Tier 3
5 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market by Type
  1. 5.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type
  2. 5.1.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type
  6. 5.2.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Type
6 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market by Application
  1. 6.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application
  2. 6.1.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application
  6. 6.2.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Application
7 Company Profiles
  1. 7.1 CSL
  2. 7.1.1 CSL Company Information
  3. 7.1.2 CSL Business Overview
  4. 7.1.3 CSL Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CSL Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product Portfolio
  6. 7.1.5 CSL Recent Developments
  7. 7.2 Biotest
  8. 7.2.1 Biotest Company Information
  9. 7.2.2 Biotest Business Overview
  10. 7.2.3 Biotest Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Biotest Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product Portfolio
  12. 7.2.5 Biotest Recent Developments
  13. 7.3 Beijing Tiantan Biological Products
  14. 7.3.1 Beijing Tiantan Biological Products Company Information
  15. 7.3.2 Beijing Tiantan Biological Products Business Overview
  16. 7.3.3 Beijing Tiantan Biological Products Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Beijing Tiantan Biological Products Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product Portfolio
  18. 7.3.5 Beijing Tiantan Biological Products Recent Developments
  19. 7.4 Shanxi Kangbao Biological Product
  20. 7.4.1 Shanxi Kangbao Biological Product Company Information
  21. 7.4.2 Shanxi Kangbao Biological Product Business Overview
  22. 7.4.3 Shanxi Kangbao Biological Product Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Shanxi Kangbao Biological Product Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product Portfolio
  24. 7.4.5 Shanxi Kangbao Biological Product Recent Developments
  25. 7.5 Taibang Biologic Group
  26. 7.5.1 Taibang Biologic Group Company Information
  27. 7.5.2 Taibang Biologic Group Business Overview
  28. 7.5.3 Taibang Biologic Group Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Taibang Biologic Group Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product Portfolio
  30. 7.5.5 Taibang Biologic Group Recent Developments
8 North America
  1. 8.1 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Type
  2. 8.1.1 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2021-2032)
  3. 8.1.2 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2021-2032)
  4. 8.1.3 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Type (2021-2032)
  5. 8.2 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Application
  6. 8.2.1 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2021-2032)
  7. 8.2.2 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2021-2032)
  8. 8.2.3 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Application (2021-2032)
  9. 8.3 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Country
  10. 8.3.1 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Type
  2. 9.1.1 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2021-2032)
  4. 9.1.3 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Type (2021-2032)
  5. 9.2 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Application
  6. 9.2.1 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2021-2032)
  8. 9.2.3 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Application (2021-2032)
  9. 9.3 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Country
  10. 9.3.1 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Type
  2. 10.1.1 China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2021-2032)
  3. 10.1.2 China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2021-2032)
  4. 10.1.3 China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Type (2021-2032)
  5. 10.2 China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Application
  6. 10.2.1 China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2021-2032)
  7. 10.2.2 China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2021-2032)
  8. 10.2.3 China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Type
  2. 11.1.1 Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2021-2032)
  4. 11.1.3 Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Type (2021-2032)
  5. 11.2 Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Application
  6. 11.2.1 Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2021-2032)
  8. 11.2.3 Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Application (2021-2032)
  9. 11.3 Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Country
  10. 11.3.1 Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Type
  2. 12.1.1 SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Type (2021-2032)
  5. 12.2 SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Application
  6. 12.2.1 SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Application (2021-2032)
  9. 12.3 SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Country
  10. 12.3.1 SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Value Chain Analysis
  2. 13.1.1 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Production Mode & Process
  6. 13.2 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Distributors
  9. 13.2.3 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst